These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22020899)

  • 1. The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.
    Cho HS; Toyokawa G; Daigo Y; Hayami S; Masuda K; Ikawa N; Yamane Y; Maejima K; Tsunoda T; Field HI; Kelly JD; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
    Int J Cancer; 2012 Aug; 131(3):E179-89. PubMed ID: 22020899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6.
    Toyokawa G; Cho HS; Iwai Y; Yoshimatsu M; Takawa M; Hayami S; Maejima K; Shimizu N; Tanaka H; Tsunoda T; Field HI; Kelly JD; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2051-61. PubMed ID: 21930796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.
    Chen J; Zhang J; Yang J; Xu L; Hu Q; Xu C; Yang S; Jiang H
    Atherosclerosis; 2017 Feb; 257():152-163. PubMed ID: 28135625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice.
    Dandawate P; Ghosh C; Palaniyandi K; Paul S; Rawal S; Pradhan R; Sayed AAA; Choudhury S; Standing D; Subramaniam D; Padhye SB; Gunewardena S; Thomas SM; Neil MO; Tawfik O; Welch DR; Jensen RA; Maliski S; Weir S; Iwakuma T; Anant S; Dhar A
    Gastroenterology; 2019 Dec; 157(6):1646-1659.e11. PubMed ID: 31442435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.
    Toyokawa G; Cho HS; Masuda K; Yamane Y; Yoshimatsu M; Hayami S; Takawa M; Iwai Y; Daigo Y; Tsuchiya E; Tsunoda T; Field HI; Kelly JD; Neal DE; Maehara Y; Ponder BA; Nakamura Y; Hamamoto R
    Neoplasia; 2011 Oct; 13(10):887-98. PubMed ID: 22028615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
    Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
    Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
    Ramadoss S; Guo G; Wang CY
    Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone Demethylase KDM3 (JMJD1) in Transcriptional Regulation and Cancer Progression.
    Fan L; Sudeep K; Qi J
    Adv Exp Med Biol; 2023; 1433():69-86. PubMed ID: 37751136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway.
    Hayami S; Yoshimatsu M; Veerakumarasivam A; Unoki M; Iwai Y; Tsunoda T; Field HI; Kelly JD; Neal DE; Yamaue H; Ponder BA; Nakamura Y; Hamamoto R
    Mol Cancer; 2010 Mar; 9():59. PubMed ID: 20226085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A.
    Kim KY; Huerta SB; Izumiya C; Wang DH; Martinez A; Shevchenko B; Kung HJ; Campbell M; Izumiya Y
    J Virol; 2013 Jun; 87(12):6782-93. PubMed ID: 23576503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone demethylase JMJD1A in cancer progression and therapeutic resistance.
    Jeon HY; Ryu H; Pornour M; Qi J
    Mol Carcinog; 2022 Apr; 61(4):392-396. PubMed ID: 35020958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G(1)/S transition.
    Kogure M; Takawa M; Cho HS; Toyokawa G; Hayashi K; Tsunoda T; Kobayashi T; Daigo Y; Sugiyama M; Atomi Y; Nakamura Y; Hamamoto R
    Cancer Lett; 2013 Aug; 336(1):76-84. PubMed ID: 23603248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1.
    Mahajan K; Lawrence HR; Lawrence NJ; Mahajan NP
    J Biol Chem; 2014 Oct; 289(41):28179-91. PubMed ID: 25148682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles-encapsulated let-7i shed from bone mesenchymal stem cells suppress lung cancer via KDM3A/DCLK1/FXYD3 axis.
    Liu J; Feng Y; Zeng X; He M; Gong Y; Liu Y
    J Cell Mol Med; 2021 Feb; 25(4):1911-1926. PubMed ID: 33350586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model.
    Zhao QY; Lei PJ; Zhang X; Zheng JY; Wang HY; Zhao J; Li YM; Ye M; Li L; Wei G; Wu M
    Clin Epigenetics; 2016; 8():34. PubMed ID: 27034728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.
    Kang D; Cho HS; Toyokawa G; Kogure M; Yamane Y; Iwai Y; Hayami S; Tsunoda T; Field HI; Matsuda K; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
    Genes Chromosomes Cancer; 2013 Feb; 52(2):126-39. PubMed ID: 23011637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
    Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
    Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer.
    Hou X; Li Q; Yang L; Yang Z; He J; Li Q; Li D
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1869-1883. PubMed ID: 34171978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.
    Wade MA; Jones D; Wilson L; Stockley J; Coffey K; Robson CN; Gaughan L
    Nucleic Acids Res; 2015 Jan; 43(1):196-207. PubMed ID: 25488809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
    Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kim HH; Kwak C
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.